API & Bulk Drug Synthesis Execution
Master formula execution, solvent recovery tracking, yield mass balance, and mother liquor logging engineered for Hyderabad's synthetic chemistry plants.
Solution · Telangana & Hyderabad Hub
Enterprise Pharma GxP Software in Hyderabad & Genome Valley | Novaqis
DMS, LIMS, LMS, QMS & EBR for Hyderabad's bulk drug, API, vaccine, and formulation corridor
Hyderabad is India's bulk drug and vaccine capital, home to world-class manufacturing across Genome Valley, Bachupally, Jeedimetla, Pashamylaram, and Patancheru. Novaqis delivers high-performance GxP digital quality operations (DMS, LIMS, LMS, QMS, and BRM) with 21 CFR Part 11 validation, sovereign on-premise installation, and transparent enterprise site licensing.
- Hyderabad Pharma Ready
- 21 CFR Part 11 Validated
- API Synthesis Focused
- Zero Seat Tax
Product preview
See it in the platform
Sample tracking, instrument acquisition, and stability pull schedules
Novaqis LIMS
LIMS / Lab Dashboard
Laboratory Testing & Sample Workload Hub
21 CFR Part 11Nova AI
Capabilities
What you get
High-Throughput QC Lab Automation (Novaqis LIMS)
22-module paperless LIMS with bidirectional Empower and Chromeleon instrument interfacing, USP <711> dissolution, and 2-phase OOS root-cause investigations.
Sovereign On-Premises Deployment
Run 100% air-gapped on your private factory servers with offline ES256 cryptographic licensing and zero external cloud data dependency.
Zero Per-Seat License Penalties
Predictable plant-wide enterprise licensing covering unlimited operators, analysts, QA reviewers, and contract staff without user seat taxes.
Compliance & control
Built for regulated operations
Audit trails, electronic signatures, role-based access, and deployment choices designed for GxP validation, not bolted on after the fact.
CapabilityHow Novaqis delivers it
- API Mass Balance & Solvent Tracking
Real-time calculation of theoretical yields, solvent recovery distillation logs, and LOD parameters.
- Instrument IoT Integration
IDAS middleware connects directly to HPLC, GC, and balances for zero-transcription test recording.
- US FDA 21 CFR Part 11 Architecture
Dual-credential e-signatures, immutable ALCOA+ audit trails, and GAMP 5 Category 4 CSV documentation.
Outcomes
Why teams choose Novaqis
- 100% elimination of paper batch binders and manual calculation errors
- Turnkey US FDA 21 CFR Part 11 and CDSCO Schedule M compliance
- Rapid 6-week plant rollout across multi-site Hyderabad manufacturing units
- Dedicated local deployment and validation support
FAQ
Frequently asked questions
- Yes. Novaqis supports complete on-site deployment, CSV validation execution, and hypercare onboarding across plants in Genome Valley, Bachupally, Jeedimetla, and Patancheru.